TNFRSF9 and neoplasm: Importantly, a mouse-specific surrogate version of FS120 (hereinafter referred to as FS120m) induced antitumor activity in a CT26 tumor model, which was associated with reduced liver T-cell infiltration when compared with other agonist antibodies targeting CD137, as an indication of reduced off-target toxicity (45).